Calibrating single plasmonic nanostructures for quantitative biosening
10345287 ยท 2019-07-09
Assignee
Inventors
- Marc P. Raphael (Washington, DC, US)
- Joseph A. Christodoulides (Alexandria, VA, US)
- Jeff M. Byers (Fairfax Station, VA, US)
Cpc classification
B82Y15/00
PERFORMING OPERATIONS; TRANSPORTING
International classification
G01N21/27
PHYSICS
B82Y15/00
PERFORMING OPERATIONS; TRANSPORTING
Abstract
A method for calibrating multiple nanostructures in parallel for quantitative biosensing using a chip for localized surface plasmon resonance (LSPR) biosensing and imaging. The chip is a glass coverslip compatible for use in a standard microscope with at least one array of functionalized plasmonic nanostructures patterned onto it using electron beam nanolithography. The chip is used to collect CCD-based LSPR imagery data of each individual nanostructure and LSPR spectral data of the array. The spectral data is used to determine the fractional occupancy of the array. The imagery data is modeled as a function of fractional occupancy to determine the fractional occupancy of each individual nanostructure.
Claims
1. A method for calibrating multiple nanostructures in parallel for quantitative biosensing, comprising: fabricating at least one array of functionalized plasmonic nanostructures for localized surface plasmon resonance (LSPR) biosensing and imaging on a glass coverslip compatible for use in a standard microscope using electron beam nanolithography; simultaneously measuring CCD-based LSPR imagery data of each individual nanostructure and LSPR spectral data of the array; analyzing the LSPR spectral data of the array to determine the fractional occupancy of the entire array; analyzing the imagery data to determine the fractional occupancy of individual nanostructures; creating an image map to show a deviation between the fractional occupancy of the entire array and the fractional occupancy of individual nanostructures; and calibrating for quantitative biosensing only individual nanostructures within a defined deviation while ignoring nanostructures outside of the defined deviation.
2. The method of claim 1, wherein the functionalized plasmonic nanostructures comprise functionalized gold plasmonic nanostructures.
3. The method of claim 1, wherein the pitch between the arrays is in the range from 150 to 1000 nm.
4. The method of claim 1, wherein the size of the patterned nanostructures is in the range from 50 to 150 nm.
5. The method of claim 1, wherein the shape of the nanostructures comprises rectangles, squares, discs, ovals, or any combination thereof.
6. The method of claim 1, wherein the nanostructure arrays can be regenerated.
7. The method of claim 6, wherein the nanostructure arrays are regenerated by plasma ashing.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
DETAILED DESCRIPTION OF THE INVENTION
(5) The present invention provides a localized surface plasmon resonance (LSPR) imaging and analysis technique that enables the calibration of hundreds of individual gold nanostructures in parallel. The calibration enables the mapping of the fractional occupancy of surface-bound receptors at individual nanostructures with a temporal resolution of 225 ms. Some features of this invention are (1) the fabrication of the arrays by electron-beam lithography for the production of highly uniform nanostructures, as confirmed by both size and spectral characterizations (2) the simultaneous measurement of spectra and imagery and (3) the combination of the spectral and imagery data into an analysis formalism that enables the determination of the fractional occupancy of surface bound receptors at individual nanostructures, f(r, t), where r denotes the location on the substrate and t denotes time. In addition, the technique is fully compatible with fluorescence and DIC microscopy techniques and can be used in complex fluid environments like serum free medium without degradation of the sensors.
(6) Using the present invention, the imagery of single nanostructures can encode the same information as the ensemble measurement of the entire array as measured spectroscopically. In other words, if the array is subjected to a uniform spatial distribution of analyte, the optical response of nanostructure-sized regions of interest (ROIs) can be calibrated to that of the ensemble fractional occupancy found by spectroscopy. It is not obvious that this should be possible since the image sums up all the spectral information and individual nanostructures can be subject to stochastic processes that average away when the entire array is used. Using an array of four hundred nanostructures, it was demonstrated that this technique allows for the qualitative detection of commercially available anti-c-myc antibodies with single nanostructure resolution using only a CCD camera. Using the same array of nanostructures, the calibration methodology that enables the quantification of the CCD-based measurements for the determination of f(r,t) is detailed. As a demonstration of this technique's applicability to molecular and cell biology, the calibrated array was used for quantitative LSPR imaging of anti-c-myc antibodies that were harvested from the hybridoma cell line 9E10 without the need for their further purification or processing. All experiments were conducted in the same serum free medium (SFM) used for cell culturing applications.
(7) Fabrication and Functionalization of the Nanostructures
(8) The nanostructures were fabricated on No. 1.5, 25.4 mm diameter borosilicate glass coverslips by electron-beam lithography (EBL). The structures were circular in cross section with a diameter 705 nm, 752 nm in height, and patterned into 2020 arrays with a spacing of 400 nm. The chip was cleaned by plasma ashing in 5% hydrogen, 95% argon mixture and then functionalized by immersion in a two-component thiol solution (0.5 mM), consisting of a 3:1 ratio of SH(CH.sub.2).sub.8-EG.sub.3-OH (SPO) to SH(CH.sub.2).sub.11-EG.sub.3-NH.sub.2 (SPN), for 18 hours (Prochimia, Poland). The SPN component of the SAM layer was first reacted with a 10 mg/mL solution of the heterobifunctional crosslinker sulfo-N-succinimidyl-4-formylbenzamide (Sulfo-S-4FB, Solulink) in 100 mM phosphate buffered saline (100 mM PBS, Thermo Scientific) and then conjugated to the c-myc peptide (HyNic-c-myc-tag, Solulink) according to the manufacturer's instructions. Anti-c-myc secreting hybridoma cells (MYC1-9E10.2, ATCC) were adapted to growth in serum-free medium containing 1% antibiotic/antimycotic by the sequential, stepwise reduction in fetal bovine serum content over a one-month culture period. The secretion of the 9E10.2 monoclonal antibodies (anti-c-myc) was confirmed and quantified by enzyme-linked immunosorbent assay (ELISA) using a BSA-c-myc peptide conjugate (7 c-myc peptides per BSA) as the immobilized antigen (coated overnight at 5 g/mL in 100 mM PBS at 4 C.). The details of the nanostructure fabrication by EBL, plasma ashing procedure and application of the SAM layer are described in M. P. Raphael et al., A New Methodology for Quantitative LSPR Biosensing and Imaging, Anal. Chem., 84(3), 1367-73 (2012).
(9) Optical Setup
(10) CCD-based LSPR imaging, as well as LSPR spectra, were collected in a reflected light geometry with an inverted microscope (Zeiss Axio Observer) using Koehler illumination, a 63, 1.4 numerical aperture (NA) oil-immersion objective and crossed-polarizers to reduce the background contribution from substrate-scattered light. Imagery and spectra were obtained simultaneously by placing a beam splitter at the output port of the microscope (
(11) Qualitative Biosensing with Single Nanostructures
(12) The imagery as well as LSPR spectra were simultaneously acquired by passing the reflected light through a 50/50 beam splitter (BS) as shown in
(13) The calibration of hundreds of nanostructures in batch mode requires that the spectral properties of individual nanostructures closely resemble that of the array ensemble average. Topological studies of the nanostructures by AFM revealed small variations in nanostructure shape due to the fabrication process (
(14)
(15)
where m.sub.i is the number of pixels in the ROI denoted as r.sub.i and t.sub.n is the time point. Also shown is a drift study that preceded the introduction of analyte (black squares) in which SFM flowed over the array for 30 minutes at 10 L/min. In contrast to simple buffers, SFM typically contains anywhere from 50 mg/L to 1000 mg/L of additional proteins such as albumin, transferrin and insulin, which can potentially bio-foul the sensors. Despite this presence, the measurements demonstrated minimal drift, and sensitivity to analyte was retained. Additional studies demonstrating minimal non-specific binding studies between the antibody and the SAM-functionalized surface were conducted using a Bio-Rad XPR36 surface plasmon resonance instrument.
(16)
(17)
(18) Quantitative Biosensing with Single Nanostructures
(19) We have previously reported a methodology that allows for the determination of the fractional occupancy of the entire array from the spectral data, denoted here as f.sub.s(t). (M. P. Raphael et al., A New Methodology for Quantitative LSPR Biosensing and Imaging, Anal. Chem., 84(3), 1367-73 (2012)). In short, the number of counts at wavelength, , accumulated by the spectrometer during time interval t.sub.n can be written as a linear response model with Poisson counting noise, .sub.Poisson, in terms of the f.sub.s for a specifically-bound monolayer perturbing the localized surface plasmon resonance:
N.sub.(t.sub.n)=g(t.sub.n).Math.[a.sub.f.sub.S(t.sub.n)+b.sub.]+.sub.Poisson(2)
The model parameters a.sub. and b.sub. represent the wavelength-dependent dielectric response caused by the bound analyte and the initial background of the LSPR array, respectively. The overall time-dependent coefficient, g(t.sub.n), is initially set to one at the beginning of the experiment but can account for drift and jump processes that cause variations in the scattered light intensity with no wavelength dependence. Generally, g(t.sub.n)1 and can be ignored in most situations. For a given nanostructure array and experimental conditions the b.sub. is determined when no analyte is present at the beginning of the experiment and the a.sub. is determined by the injection of a saturating injection of known concentration at the end of the experiment. The time-dependent functions g(t.sub.n) and f.sub.S(t.sub.n) can be determined by non-linear regression within a Poisson noise model for the counts at each time interval, t.sub.n.
(20) To assess whether the imagery of single nanostructures can capture the fractional occupancy information found in whole-array spectroscopy, a simple generative model is proposed for how the image data is formed, similar to that used in analyzing the spectroscopy data:
I(r.sub.i,t.sub.n)=A(r.sub.i).Math.f.sub.I(r.sub.i,t.sub.n)+B(r.sub.i)+.sub.Poisson(3)
Here the model parameters a.sub. and b.sub. are analogously represented by the spatially dependent parameters A(r.sub.i) and B(r.sub.i) for the determination of the fractional occupancy from the image data, f.sub.I(r.sub.i,t.sub.n). Since the size of the array is small compared to the diffusion length of the analyte over the exposure time of the CCD camera, the concentration is effectively uniform. This allows A(r.sub.i) and B(r.sub.i) to be determined via multi-variate linear regression by setting f.sub.I(r.sub.i,t.sub.n)=f.sub.S(t.sub.n), thus, calibrating the entire array via imagery. Once the array is calibrated, inhomogeneous fractional occupancy can be estimated as:
(21)
In order to determine if this relatively simple treatment of the imagery data is effective, the variance in the local response, {circumflex over (f)}.sub.I(r.sub.i,t.sub.n), of the nanostructure array from f.sub.S(t.sub.n) over the ROIs can be calculated:
(22)
The resulting image map will show what parts of the array are capable of being calibrated for the determination of the local fractional occupancy.
(23) As an example of the applicability of this approach to molecular and cell biology, the determination of fractional occupancy versus time at the nanoscale to the secreted antibodies contained within the supernatant of cultured MYC1-9E10.2 hybridoma cells was demonstrated. The harvested antibodies experiment was conducted by simply centrifuging the cells at 3000 rpm for 5 minutes, collecting the supernatant and applying that solution to the nanostructures via the microfluidic setup at a flow rate of 10 L/min. The concentration of secreted anti-c-myc antibodies in the supernatant was independently determined by ELISA to be 9 nM. The nanostructure calibration was conducted as described above by introducing a known concentration of commercial anti-c-myc (250 nM) over the nanostructures immediately following the harvested antibody experiment.
(24)
(25) The results of the 44 pixel sliding ROI calibration and analysis are summarized in
(26) The results in
(27) The above descriptions are those of the preferred embodiments of the invention. Various modifications and variations are possible in light of the above teachings without departing from the spirit and broader aspects of the invention. It is therefore to be understood that the claimed invention may be practiced otherwise than as specifically described. Any references to claim elements in the singular, for example, using the articles a, an, the, or said, is not to be construed as limiting the element to the singular.